X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

Innovative Cold Chain Logistics For Pharmaceutical Products

Content Team by Content Team
26th August 2023
in Facilities & Operation, Featured, News
Innovative Cold Chain Logistics For Pharmaceutical Products

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Pharmaceutical products undergo an extensive journey from lab to patient, traversing various modes of transportation in the supply chain. The last leg of this journey, known as the “last mile,” becomes particularly complex in the cold chain. This stage begins at the final transportation hub and involves direct delivery to consumers. Challenges arise when these temperature-sensitive pharmaceuticals must be transported and stored under controlled conditions.

Maintaining optimal temperature and humidity levels within a seamless cold supply chain is essential to uphold the quality and integrity of these delicate products and ensure patient safety. The selection of an appropriate temperature-controlled container becomes a critical factor in the success of transportation and delivery. Market trends are shaping last-mile deliveries, driven by the rise of sensitive biopharmaceutical and biologic products. Precision therapies tailored to an individual’s genetic makeup are becoming more prominent, leading to a demand for customized medical interventions. This shift necessitates adjustments in supply chain approaches, as smaller batch medicines and personalized treatments become the norm.

The globalization of cold chains is driven by rapid product development and the demand for advanced pharmaceuticals in various regions, including middle to low-income countries. This requires logistic providers to establish global networks for localized, reliable delivery while adhering to diverse regulations.

Considering the value and perishable nature of pharmaceuticals, coupled with the challenges of final leg shipping, cold chain providers must have the technology and resources to handle small volumes of products within tight timeframes. Passive temperature-controlled solutions are gaining traction as a way to mitigate risks. These solutions maintain consistent temperatures for extended periods without requiring an active energy source, making them reliable for diverse supply chains.

The pressure is on various stakeholders to enhance their capabilities in supporting the life sciences industry while adhering to regulatory standards. Digitalization is emerging as a solution to meet these demands. Smart packaging with traceability and real-time data monitoring is now a fundamental aspect of supply chain management, ensuring compliance and providing visibility to customers.

Beyond the technical aspects of containers, pharmaceutical manufacturers are seeking sustainable partnerships. External partners are evaluated based on their commitment to carbon neutrality, use of renewable energy sources, and efforts to reduce emissions. These factors contribute to sustainability goals in the last-mile pharmaceutical supply chain.

Previous Post

Biologics And Regulations Propel Aseptic Fill-Finish Growth

Next Post

Evolving Trends In Pharma Temperature-Controlled Packaging

Related Posts

WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Construction of WuXi Biologics Microbial Manufacturing Site
News

Construction of WuXi Biologics Microbial Manufacturing Site

19th June 2025
Beyfortus From Sanofi to Make Imprint in 2025 26 RSV Season
News

Beyfortus From Sanofi to Make Imprint in 2025-26 RSV Season

19th June 2025
Thermo-Fischer-Accelerator Drug Development an Ideal Choice
News

Thermo Fischer Accelerator Drug Development an Ideal Choice

19th June 2025
IQVIA Custom Built AI Agents for Life Sciences Healthcare
News

IQVIA Custom-Built AI Agents for Life Sciences, Healthcare

19th June 2025
SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Next Post

Evolving Trends In Pharma Temperature-Controlled Packaging

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In